1. The Synthetic Compound CC-5079 Is a Potent Inhibitor of Tubulin Polymerization and Tumor Necrosis Factor-α Production with Antitumor Activity
   Ling-Hua Zhang et al, 2006, Cancer Research CrossRef
2. Lx2-32c, a Novel Taxane Derivative, Exerts Anti-resistance Activity by Initiating Intrinsic Apoptosis Pathway in Vitro and Inhibits the Growth of Resistant Tumor in Vivo
   Qing Zhou et al, 2012, Biological and Pharmaceutical Bulletin CrossRef
3. β-Tubulin Mutations Are Associated with Resistance to 2-Methoxyestradiol in MDA-MB-435 Cancer Cells
   Yesim Gökmen-Polar et al, 2005, Cancer Research CrossRef
4. Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb β-Tubulin in Vinca Alkaloid Sensitivity
   Pei Pei Gan et al, 2008, Cancer Research CrossRef
5. Stimuli-Responsive Self-Healing Viscoelastic Gels
   Rekha Goswami Shrestha et al, 2017, Stimuli-Responsive Interfaces CrossRef
6. Neuronal-associated microtubule proteins class III β-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs
   Sima Don et al, 2004, Molecular Cancer Therapeutics CrossRef
7. Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine
   Marie-Anne Estève et al, 2006, Molecular Cancer Therapeutics CrossRef
8. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus , in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo
   Cho-Hwa Liao et al, 2005, Carcinogenesis CrossRef
9. Overexpression of Kinesins Mediates Docetaxel Resistance in Breast Cancer Cells
   Sarmishtha De et al, 2009, Cancer Research CrossRef
10. Natural Products as Cytotoxic Agents
    Mallory Pullman et al, 2021, Burger's Medicinal Chemistry and Drug Discovery CrossRef
11. Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein Expression
    Roisean E. Ferguson et al, 2005, Clinical Cancer Research CrossRef
12. The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase
    Adam I. Marcus et al, 2005, Cancer Research CrossRef
13. Quantification and Analysis of Combination Drug Synergy in High-Throughput Transcriptome Studies
    Zeynep H. Gümüs et al, 2010, 2010 IEEE International Conference on BioInformatics and BioEngineering CrossRef
14. Regulation of Tubulin Gene Expression: From Isotype Identity to Functional Specialization
    Ivana Gasic, 2022, Frontiers in Cell and Developmental Biology CrossRef
15. Heterocyclic Compounds: Importance in Anticancer Drug Discovery
    Naresh Kumar et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
16. Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma
    Daisuke Aoki et al, 2009, Clinical Cancer Research CrossRef